Nipro Recalls GlucoPro Insulin Syringes

Comments
Print

WASHINGTON—Miami-based Nipro Medical Corporation has initiated a nationwide recall of all GlucoPro Insulin Syringe because they may have needles that detach from the syringe, according to the U.S. Food and Drug Administration.

The product has been distributed across the United States and in Puerto Rico. No injuries have been reported, according to the FDA.

This recall does not include the GlucoPro syringe specific for use with the Amigo Insulin pump, according to the FDA. “If the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection,” the agency said in a Jan. 21 news release.

Consumers who have GlucoPro Insulin Syringes should stop using and return them to point of sale for reimbursement, according to the FDA.

This recall includes all product codes and lot numbers with expiration dates before 2011-11 (Nov 1, 2011).

The FDA said Nipro is notifying its distributors and customers by fax and email and is arranging for return of all recalled products. Consumers with questions may contact the company at (305) 599-7174 ext. 249.

Comments
comments powered by Disqus